• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications.

作者信息

Fox W, Ellard G A, Mitchison D A

机构信息

St George's Hospital Medical School, London, UK.

出版信息

Int J Tuberc Lung Dis. 1999 Oct;3(10 Suppl 2):S231-79.

PMID:10529902
Abstract
摘要

相似文献

1
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications.英国医学研究理事会结核病研究单位于1946年至1986年开展的结核病治疗研究及相关后续出版物。
Int J Tuberc Lung Dis. 1999 Oct;3(10 Suppl 2):S231-79.
2
Effect of multidrug resistance on global tuberculosis control.多重耐药对全球结核病控制的影响。
Lancet. 2003 Nov 29;362(9398):1858-9. doi: 10.1016/S0140-6736(03)14918-5.
3
[Treatment of drug resistant tuberculosis].[耐多药结核病的治疗]
Antibiot Khimioter. 2003;48(8):28-36.
4
DOTS in Haiti.海地的直接观察短程疗法。
Int J Tuberc Lung Dis. 2000 Mar;4(3):282-3.
5
Patients with previously treated tuberculosis no longer neglected.曾接受过治疗的结核病患者不再被忽视。
Clin Infect Dis. 2007 Jan 1;44(1):61-4. doi: 10.1086/509328. Epub 2006 Nov 20.
6
Tuberculosis and antimicrobial resistance - new models of research and development needed.结核病与抗菌药物耐药性——需要新的研发模式。
Bull World Health Organ. 2017 May 1;95(5):315. doi: 10.2471/BLT.17.194837.
7
Taming tuberculosis: a challenge for science and society.驯服结核病：科学与社会面临的挑战
Cell Host Microbe. 2009 Mar 19;5(3):220-4. doi: 10.1016/j.chom.2009.02.004.
8
The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control.抗结核化疗药物耐药性日益普遍：对全球结核病控制的影响。
Curr Clin Top Infect Dis. 1992;12:188-207.
9
[Chemotherapy of tuberculosis. II - Drugs. Types of treatment. Evaluation and control].
AMB Rev Assoc Med Bras. 1983 May-Jun;29(5-6):94-101.
10
Rational use of moxifloxacin for tuberculosis treatment.莫西沙星在结核病治疗中的合理应用。
Lancet Infect Dis. 2011 Apr;11(4):259-60. doi: 10.1016/S1473-3099(11)70036-6.

引用本文的文献

1
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science.推进结核病防治工作：在诊断、治疗、疫苗研发及实施科学方面整合创新与公共卫生。
Front Med (Lausanne). 2025 Aug 25;12:1596579. doi: 10.3389/fmed.2025.1596579. eCollection 2025.
2
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.ACTG A5409（放射治疗肺结核）：一项2期随机、适应性、剂量范围、开放标签试验的研究方案，该试验旨在研究治疗肺结核的新型方案。
Trials. 2025 Aug 15;26(1):291. doi: 10.1186/s13063-025-08973-w.
3
Bridging science and policy in tuberculosis treatment through innovations in precision medicine, drug development, and cohort research: a narrative review.
通过精准医学、药物研发和队列研究创新在结核病治疗中搭建科学与政策的桥梁：一项叙述性综述
Ewha Med J. 2025 Apr;48(2):e22. doi: 10.12771/emj.2025.00115. Epub 2025 Apr 2.
4
Dinucleotide codon substitutions as a signature of diversifying selection in .二核苷酸密码子替换作为……中多样化选择的标志
Front Mol Biosci. 2025 Jul 2;12:1511372. doi: 10.3389/fmolb.2025.1511372. eCollection 2025.
5
Clinical factors associated with surgical interventions in patients with intestinal obstruction caused by abdominal tuberculosis.腹部结核所致肠梗阻患者手术干预的相关临床因素。
Surg Today. 2025 Jul 8. doi: 10.1007/s00595-025-03098-8.
6
Strategies for shortening tuberculosis therapy.缩短结核病治疗疗程的策略。
Nat Med. 2025 Jun;31(6):1765-1775. doi: 10.1038/s41591-025-03742-3. Epub 2025 Jun 13.
7
History of clinical trials for the treatment of tuberculosis in China. Part 1: early 'translational' work and observational and non-randomised studies.中国结核病治疗临床试验史。第1部分：早期“转化”工作以及观察性和非随机研究。
J R Soc Med. 2025 May;118(5):167-172. doi: 10.1177/01410768251337675. Epub 2025 May 27.
8
Next-generation rifamycins for the treatment of mycobacterial infections.用于治疗分枝杆菌感染的新一代利福霉素类药物。
Proc Natl Acad Sci U S A. 2025 May 6;122(18):e2423842122. doi: 10.1073/pnas.2423842122. Epub 2025 May 1.
9
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.ACTG A5409（RAD-TB）：一项针对治疗肺结核的新型方案的2期随机、适应性、剂量范围、开放标签试验的研究方案。
Res Sq. 2025 Mar 26:rs.3.rs-5931694. doi: 10.21203/rs.3.rs-5931694/v1.
10
Structure-Based Analysis of Semisynthetic Anti-TB Rufomycin Analogues.基于结构的半合成抗结核鲁福霉素类似物分析
J Nat Prod. 2025 Apr 25;88(4):907-925. doi: 10.1021/acs.jnatprod.4c01266. Epub 2025 Mar 24.